Genea Canberra celebrates 15 years

More than 1,600 babies have been born to local parents over the past 15 years with the help of Genea Canberra.

The clinic marks its 15 year anniversary and proudly celebrates the combination of pioneering technology and personalised care that has helped to make the dream of parenthood a reality for these families.

Genea Canberra Fertility Specialist Dr Tween Low said, "Over the past 15 years we have seen huge developments in the fertility sector. Genea has truly led these innovations, committed to continually improving technologies to maximise patients’ potential to have a baby." She added, "It’s the combination of world leading science and personalised care that I believe makes the difference for our patients."

The figures speak for themselves, eight out of ten patients who started treatment elsewhere wish they came to Genea first and importantly, only 50% of patients who see a Genea Fertility Specialist actually require IVF.

"Not every clinic is created equal, leading technologies and care play a crucial role in supporting families to have a baby in the least number of stimulated cycles," says Dr Low.

Genea’s sister company, Genea Biomedx creates and manufactures practical, accessible and precise fertility technologies that help standardise and automate fertility treatment. As a technology company with direct access to a world leading fertility lab, Genea is in a unique position, to innovate fertility treatment, with insight into the needs and challenges of patients, doctors and scientists.

Genea Biomedx technologies are exclusive to Genea laboratories. Genea’s Embryo Review Incubator (Geri®) is a unique benchtop instrument with individually controlled incubation chambers per patient to minimise disturbance to the early-stage embryo, it also incorporates a camera for continuous monitoring of embryos as they develop. Genea Canberra has recently launched Grow by Genea®, an Australian first app allowing patients 24/7 access to photos and videos of their embryos during the six days they spend growing in a Geri incubator in the embryology lab. Gavi®, the world’s first automated vitrification instrument is also found in Genea Canberra labs, automating and standardising key stages of the embryo freezing process. The latest generation of Genea’s culture media, Gems®, the vital solution that supports embryo development outside the body is another Genea Biomedx innovation that is exclusive to Genea laboratories.

"Geri®, Grow®, Gavi® and Gems® are just three recent examples of the innovations that set Genea apart. We have always been at the forefront of fertility treatment and look forward to bringing joy to more local Canberra patients over the next 15 years," said Dr Low.
Download a PDF of the press release

Meline Walton
Media & Communications Manager
M +61 452 433 369